Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin B1, also known as thiamine (specifically in its active form thiamine diphosphate), has some scientific basis for use in the management of certain types of dementia, though the evidence is limited and primarily pertains to conditions associated with thiamine deficiency. Wernicke-Korsakoff syndrome, a neuropsychiatric disorder that can include a dementia-like state, is directly linked to thiamine deficiency and is most commonly seen in cases of chronic alcoholism or severe malnutrition. In this context, thiamine supplementation is an established and effective treatment to prevent progression and, in some cases, partially reverse cognitive symptoms.

However, with respect to Alzheimer’s disease and other common forms of dementia, the evidence base for thiamine supplementation is less robust. Some small-scale clinical studies and observational research have suggested that individuals with dementia may have lower thiamine levels, and there are hypotheses about the role of thiamine in glucose metabolism in the brain. A few trials have tested high-dose thiamine in Alzheimer’s patients, yielding mixed results; some reported modest cognitive benefits, while others found no significant effect. Systematic reviews and major guidelines generally conclude that, outside of deficiency states, there is insufficient evidence to recommend thiamine supplementation for the treatment or prevention of typical dementias.

In summary, thiamine (vitamin B1) is scientifically validated for use in dementia related to deficiency (e.g., Wernicke-Korsakoff syndrome), but its efficacy in other dementias is currently not well-supported.

More about Vitamin B1 (thiamine diphosphate)
More about Dementia

Other ingredients used for Dementia

Other health conditions supported by Vitamin B1 (thiamine diphosphate)

Products containing Vitamin B1 (thiamine diphosphate)